India's first indigenously developed HPV test kits for cervical cancer screening validated
The HPV point-of-care test kits underwent rigorous validation by a research team at the All India Institute of Medical Sciences (AIIMS), New Delhi, in collaboration with the National Institute of Cancer Prevention and Research (NICPR), Noida, and the National Institute for Research in Reproductive and Child Health (NIRRCH), Mumbai. The validation process also included a partnership with the World Health Organization's International Agency for Research on Cancer (IARC).
The kits, which employ a chip-based RT-PCR testing method, facilitate rapid and decentralised detection of eight high-risk HPV genotypes - accounting for over 96% of cervical cancer cases worldwide. This technological advancement provides an affordable and efficient solution for widespread cervical cancer screening, particularly in resource-limited settings.
Jitendra Kumar, Managing Director of BIRAC, underscored the critical importance of accessible and accurate diagnostic tools. 'The validation of Truenat® HPV-HR Plus (Molbio) and Patho detect (Mylab) marks a significant achievement in enhancing cervical cancer screening for women across India. This initiative highlights the strength of indigenous innovation in driving early detection and saving lives,' he stated.
Cervical cancer continues to be a major health challenge in India, accounting for nearly 25% of global cases. With more than 1,23,000 new diagnoses and approximately 77,000 deaths annually, it remains the second most prevalent cancer among Indian women, despite being preventable through timely screening.
In line with the Global Declaration for Cervical Cancer Elimination, the World Health Organization (WHO) advocates for the transition to HPV testing in all countries. The WHO's goal is to ensure that by 2030, 70% of eligible women will be screened through HPV testing at age 35 and again at age 45, with only two tests required over a lifetime.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
24 minutes ago
- News18
Not Just A Stomach Ache: That Discomfort Could Be Hepatitis Hiding
For most people, a dull ache in the stomach or a wave of nausea after eating are usual signs of indigestion, but sometimes, this familiar discomfort may not be arising from the abdomen. In fact, it could be the liver's way of pointing towards more serious conditions like Hepatitis. According to the World Health Organization (WHO), hepatitis affects more than 300 million people, with India bearing one of the highest burdens in the world. This condition of the liver often hides itself until significant damage has already been done to the body. Even when its symptoms do appear, they mimic those of common digestive trouble, making diagnosis more difficult. In a situation where routine liver screening is still not that usual, the quiet symptoms of Hepatitis are unintentionally neglected until the liver starts to fail.
Time of India
3 hours ago
- Time of India
KGMU launches dedicated dept of gynaecological oncology
Lucknow: King George's Medical University (KGMU) formally launched a dedicated department of gynaecological oncology for the treatment of women cancer patients. The new department was inaugurated by Vice Chancellor Prof Soniya Nityanand at Kalam Centre on Sunday, who noted the rising number of cancer cases among women. Prof Nityanand said rising cancer cases among women led to the creation of a dedicated gynaecology department, which will provide treatment to women with cancer. During a workshop on detecting and treating early cervical cancer, Prof Nisha Singh from the department of obstetrics and gynaecology at King George's Medical University (KGMU) emphasised that every woman aged 25 to 65 should undergo cervical cancer screening every five years —even without symptoms. The event also featured live surgical demonstrations broadcast to the Kalam Centre. Prof Singh said cervical cancer is largely preventable if caught early, but often develops silently. She highlighted India's high burden—1.25 lakh new cases and 77,000 deaths annually—mostly among rural and marginalised women due to poor awareness and limited screening access. She explained that human papillomavirus (HPV) is the leading cause. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Boots is giving free 75-minute hearing checks in Livingston. Boots Hearingcare Undo While most infections clear naturally, persistent high-risk strains—especially in women with poor hygiene, multiple childbirths, early marriage, smoking, or low immunity—can lead to cancer. At KGMU, about 20 women are screened daily and even relatives of admitted patients are encouraged to participate, aided by the hospital's social work team. Women with abnormal Pap smears or HPV-positive results are referred here for further care. Prof Singh also stressed the importance of HPV vaccination, recommending it for girls aged nine to 14 before sexual activity begins. Though not yet part of India's national immunisation schedule, public acceptance is rising. She cited an awareness camp at a school for underprivileged children, where both students and parents responded positively. She noted encouraging progress: "In the past five years, we've seen more early-stage cases. Early detection allows complete surgical cure—a big step forward." The workshop aimed to train doctors to detect and treat pre-cancerous changes using simple outpatient procedures such as cryotherapy (freezing abnormal cells), thermoablation (heat-based tissue destruction), LEEP (removal with a heated wire loop), and cold knife conisation (surgical removal of a cone-shaped cervical section). These treatments are safe, effective and do not require hospital admission.
The Hindu
9 hours ago
- The Hindu
Liver diseases often go undetected; doctors call for early screening and awareness
An estimated 304 million people worldwide live with chronic hepatitis B or C, according to the World Health Organization (WHO). Of these, 254 million have hepatitis B and 50 million have hepatitis C. The disease causes about 1.3 million deaths annually over 3,500 each day. India accounts for over 11.6% of the global burden, with around 29.8 million people living with hepatitis B and 5.5 million with hepatitis C. Hepatitis is inflammation of the liver, most commonly caused by viral infections, mainly hepatitis A, B, C, D, and E. Among these, hepatitis B and C can become chronic, potentially leading to cirrhosis, liver failure or cancer. Transmission can occur through unsafe injections, blood transfusions, sexual contact or from mother to child during childbirth. Despite the scale, most infections remain undiagnosed until complications arise. Doctors say this is due to vague early symptoms, inadequate screening, and widespread misconceptions. 'In the early stages, liver trouble may show up as fatigue, appetite loss or mild abdominal pain - symptoms that are easily overlooked,' said Vivekanandan Shanmugam, Lead Liver Transplant Surgeon, SIMS Hospital, Chennai . 'Even signs like dark urine or yellowing of the eyes are ignored. As a result, patients often present late.' He added that screening for hepatitis B and C is recommended for high-risk groups - those who had blood transfusions before the 1990s, dialysis patients and healthcare workers, but implementation remains patchy. 'Many people don't know they should get tested. There is stigma and poor access, especially in peripheral areas,' he said. Dr. Shanmugam also flagged the impact of over-the-counter painkillers and unregulated herbal supplements. 'The liver filters everything we consume. Long-term misuse of common drugs like paracetamol or herbal concoctions can silently damage the liver.' Radhika Venugopal, Senior Consultant - Hepatology, Liver Disease & Transplantation, Rela Hospital, Chennai, said symptoms such as nausea, fatigue, or weight loss are often ignored. 'By the time jaundice, swelling or bleeding appears, damage is usually advanced. Liver function tests and scans can help detect problems early,' she said. She noted that hepatitis testing is not well integrated into routine healthcare, particularly in rural settings. 'Pregnant women, people with HIV, and those undergoing surgery or dialysis must be screened, but enforcement is weak.' Dr. Venugopal also flagged the rise in 'lean MAFLD' (metabolic-associated fatty liver disease) in people with normal weight but underlying metabolic issues. 'Tools like FibroScan help detect this early.' Doctors recommend hepatitis B vaccination, avoiding excessive alcohol, limiting self-medication, and routine check-ups. 'The liver is silent until it's too late,' said Dr. Shanmugam.
